Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection

Journal of Hepatology

Volumn 33, Issue 4, 2000, Pages 616-622

  Sumida, Yoshio ^a   Nakashima, Toshiaki ^a   Yoh, Takaharu ^a   Nakajima, Yoshiki ^a   Ishikawa, Hiroki ^a   Mitsuyoshi, Hironori ^a   Sakamoto, Yoshikuni ^a   Okanoue, Takeshi ^a   Kashima, Kei ^a   Nakamura, Hajime ^b   Yodoi, Junji ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Ferritin; Hepatic fibrosis; Hepatitis C virus; Interferon; Oxidative stress; Thioredoxin

Indexed keywords

FERRITIN; INTERFERON; THIOREDOXIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0033801679     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80013-6     Document Type: Article

References (48)

1. Enzymatic synthesis of deoxyribonucleotides
2. Adult T cell leukemia cells produce a lymphokine that augments interleukin 2 receptor expression
3. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: Possible involvement of dithiol-reduction in the IL-2 receptor induction
4. Redox regulation of cellular activation
5. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide
6. Oxidoreductive regulation of nuclear factor kappa-B involvement of a cellular reducing catalyst thioredoxin
7. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1
8. Thioredoxin: A redox-regulating cellular cofactor for glucocoricoid hormone action
9. Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia
10. Induction of ADF/TRX by oxidative stress in keratinocyte and lymphoid cells
11. Induction of thioredoxin in human lymphocytes with low-dose ionizing radiation
12. Elevation of plasma thioredoxin levels in HIV-infected individuals
13. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis
14. The effects of interferon-α on serum lipid peroxidation and total thiol content in patients with chronic active hepatitis-C
15. Superoxide dismutase in patients with chronic hepatitis C virus infection
16. Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C
17. Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassay
18. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: Comparison with nested amplication and antibody testing
19. Significance of specific antibody assay for genotyping of hepatitis C virus
20. New Inuyama classification; new criteria for histological assessment of chronic hepatitis
21. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
22. Sensitive enzyme-linked immunosorbent assay for adult T-Cell leukemia-derived factor and normal value measurement
23. Expression and growth-promoting effect of adult T cell leukemia-derived factor; a human thioredoxin homologue in hepatocellular carcinoma
24. Elevated serum level of thioredoxin in patients with hepatocellular carcinoma
25. Neoplasma of the liver
26. Glutathione depletion in chronic hepatitis C
27. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin
28. Immunohistochemical localization of adult T-cell leukemia-derived factor, a human thioredoxin homologue, in human fetal tissues
29. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type-I and Epstein-Barr virus-transformed lymphocytes, act as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2
30. Replication of hepatitis C virus in peripheral blood mononuclear cells: Effect of alpha interferon therapy
31. Infection of peripheral mononuclear blood cells by hepatitis C virus
32. Serum ferritin in patients with iron overload and with acute and chronic liver diseases
33. Iron overload in patients with chronic viral hepatitis: How common is it?
34. Response to interferon α therapy is influenced by the iron content of the liver
35. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C
36. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C
37. Iron and chronic viral hepatitis
38. Cytoprotective actions of estrogens against tert-butyl hydroperoxide-induced toxicity in hepatocytes
39. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology
40. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C
41. The cellular basis of hepatic fibrosis
42. A pilot study of the effects of d-α-tocopherol on hepatic stellate cell activation in chronic hepatitis C
43. Hepatic stellate cell activation in genetic haemochromatosis
44. Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitits C
45. N-acetyl cysteine enhances the response to interferon-α in chronic hepatitis C. A pilot study
46. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: A randomized, double-blind, placebo-controlled study
47. Comparison of two interferon alfa treatment regimens characterized by an early virological response in patients with chronic hepatitis C
48. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum